Chemoinformaics analysis of BICYCLO[4.3.0]NONANE, 2,2,6,7-TETRAMETHYL-7-HYDROXY-
| Molecular Weight | 196.334 | nRot | 0 |
| Heavy Atom Molecular Weight | 172.142 | nRig | 10 |
| Exact Molecular Weight | 196.183 | nRing | 2 |
| Solubility: LogS | -3.383 | nHRing | 0 |
| Solubility: LogP | 3.778 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 38.515 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.63 |
| Synth | 3.726 |
| Natural Product Likeliness | 2.691 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.016 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -4.508 |
| MDCK | 0.0000145 |
| BBB | 0.238 |
| PPB | 0.929269 |
| VDSS | 1.344 |
| FU | 0.138643 |
| CYP1A2-inh | 0.103 |
| CYP1A2-sub | 0.622 |
| CYP2c19-inh | 0.2 |
| CYP2c19-sub | 0.943 |
| CYP2c9-inh | 0.214 |
| CYP2c9-sub | 0.739 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.605 |
| CYP3a4-inh | 0.089 |
| CYP3a4-sub | 0.297 |
| CL | 10.452 |
| T12 | 0.18 |
| hERG | 0.018 |
| Ames | 0.008 |
| ROA | 0.048 |
| SkinSen | 0.231 |
| Carcinogencity | 0.04 |
| EI | 0.861 |
| Respiratory | 0.885 |
| NR-Aromatase | 0.085 |
| Antiviral | Yes |
| Prediction | 0.792807 |